QIAGEN Expands Digital PCR Portfolio with New Lentivirus Solutions

Read more

FDA Approves RINVOQ for Giant Cell Arteritis

Read more

Oxford, Boehringer, Cumulus Launch First-Ever Study on Daily Life with Psychiatric Disorders

Read more

FDA Approves ZEVASKYN, First Cell-Based Gene Therapy for RDEB

Read more

Merck Breaks Ground on $1B Biologics Center in Delaware

Read more

Prilenia Partners with Ferrer for Pridopidine in Europe and Beyond

Read more

Biohaven Secures Up to $600M Investment from Oberland Capital

Read more

Debiopharm and Oncodesign Partner to Boost Radiopharmaceuticals in Preclinical Research

Read more

Repertoire Immune and Genentech Partner on T Cell-Targeted Autoimmune Therapies

Read more

Granite Bio Debuts With $100 Million of Capital

Read more